688626.SHG Xiangyu Medical Co. Ltd. A
- Market cap
- CNY 6.36B
- P/E
- 75.0x
- P/B
- 2.90x
- ROE
- 3.8%
- Dividend yield
- 0.70%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 688626.SHG undervalued?
Graham numberThe Graham number of Xiangyu Medical Co. Ltd. A cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Xiangyu Medical Co. Ltd. A fundamental analysis
No fundamental analysis for Xiangyu Medical Co. Ltd. A yet.
Xiangyu Medical Co. Ltd. A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Xiangyu Medical Co. Ltd. A
Xiangyu Medical Co.,Ltd engages in the research, development, manufacture, and marketing of rehabilitation, physiotherapy, and pain management equipment in China. It provides various therapy devices, such as smart occupational therapy, electrotherapy, sports therapy, rehabilitation, cold and heat therapy, gait, hydrotherapy, air compression therapy, phototherapy, traction tables, magnetic therapy, continuous passive motion (CPM), shock wave and ultrasound therapy, massage th…
Full company profileXiangyu Medical Co. Ltd. A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Xiangyu Medical Co. Ltd. A annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 289M | 359M | 427M | 496M | 523M | 489M | 745M | 744M | 768M | 746M |
| Gross Profit | 170M | 226M | 279M | 333M | 354M | 318M | 501M | 491M | 768M | 505M |
| Operating Income | 77.5M | 93.9M | 147M | 223M | 224M | 135M | 245M | 109M | 77.1M | 80.7M |
| EBITDA | 84.1M | 103M | 157M | 234M | 234M | 150M | 268M | 149M | 111M | 92.1M |
| Net Income | 64.5M | 80.3M | 129M | 196M | 202M | 125M | 227M | 103M | 78.7M | 79.3M |
| EPS | 0.54 | 0.67 | 1.07 | 1.64 | 1.35 | 0.79 | 1.44 | 0.66 | 0.51 | 0.50 |
| Balance Sheet | ||||||||||
| Total Assets | 402M | 561M | 724M | 982M | 2.18B | 2.37B | 2.59B | 2.93B | 3.27B | 3.30B |
| Total Liabilities | 303M | 147M | 177M | 238M | 237M | 428M | 485M | 873M | -2.04B | 1.19B |
| Shareholders' Equity | 99.1M | 415M | 547M | 744M | 1.94B | 1.93B | 2.09B | 2.04B | 2.04B | 2.10B |
| Cash & Short-term Investments | 18.8M | 19.7M | 364M | 487M | 1.48B | 1.36B | 826M | 743M | 835M | 779M |
| Total Debt | 10.0M | - | 2.29M | 50.0M | 3.03M | 17.2M | 35.5M | 365M | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | 59.3M | 74.2M | 156M | 216M | 166M | 187M | 228M | 179M | 190M | - |
| Capital Expenditure | 14.8M | 7.02M | 21.1M | 140M | 134M | 203M | 479M | 439M | 287M | 233M |
| Free Cash Flow | 44.5M | 67.2M | 135M | 76.7M | 32.0M | -16.4M | -251M | -260M | -97.4M | -145M |
| Ratios | ||||||||||
| ROE | 65.1% | 19.4% | 23.6% | 26.4% | 10.4% | 6.5% | 10.9% | 5.0% | 3.9% | 3.8% |
| ROA | 16.1% | 14.3% | 17.8% | 20.0% | 9.3% | 5.3% | 8.8% | 3.5% | 2.4% | 2.4% |
| Net Profit Margin | 22.3% | 22.4% | 30.2% | 39.6% | 38.6% | 25.7% | 30.5% | 13.8% | 10.3% | 10.6% |
| Debt to Equity | 0.10x | - | 0.00x | 0.07x | 0.00x | 0.01x | 0.02x | 0.18x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Xiangyu Medical Co. Ltd. A dividends
- Dividend yield
- 0.70%
- Forward dividend
- 0.18 CNY
- Payout ratio
- 56.5%
- Ex-dividend date
- Jun 17, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 44.4M | 0.29 | 56.5% |
| 2024 | CNY 85.6M | 0.55 | 83.1% |
| 2023 | CNY 40.5M | 0.26 | 17.8% |
| 2022 | CNY 59.9M | 0.38 | 47.8% |
| 2021 | CNY 59.2M | 0.40 | 29.3% |
| 2020 | CNY 806K | 0.01 | 0.4% |
| 2019 | - | - | - |
| 2018 | 34.4K | 0.00 | 0.0% |
| 2017 | 101M | 0.84 | 156.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Xiangyu Medical Co. Ltd. A
- Insiders 68.01%
- Institutions 2.49%
- Public & others 29.50%
- Shares outstanding 160M
- Free float 51.7M
Xiangyu Medical Co. Ltd. A company profile
- Company name
- Xiangyu Medical Co. Ltd. A
- Ticker
- 688626.SHG
- ISIN
- CNE100005394
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 2,195
- Fiscal year end
- December
- Address
- Middle Section of Diku Road, Anyang, China, 456300
- Phone
- 86 37 2777 5555
- Website
- xyyl.com
About Xiangyu Medical Co. Ltd. A
Xiangyu Medical Co.,Ltd engages in the research, development, manufacture, and marketing of rehabilitation, physiotherapy, and pain management equipment in China. It provides various therapy devices, such as smart occupational therapy, electrotherapy, sports therapy, rehabilitation, cold and heat therapy, gait, hydrotherapy, air compression therapy, phototherapy, traction tables, magnetic therapy, continuous passive motion (CPM), shock wave and ultrasound therapy, massage therapy, treatment tables and tilt tables, and microwave and shortwave therapy devices. The company was incorporated in 2002 and is headquartered in Anyang, China.
Xiangyu Medical Co. Ltd. A management
6- Mr. Yongzheng HeChairman, GM & Technical Director · born 1972
- Mr. Hongfeng JinFinancial Director · born 1974
- Mr. Zhang JieHead of Embedded Software of R&D Center · born 1985
- Mr. Ke ZhouHead of Scenario Simulation · born 1980
- Mr. Fan DuanHead of the Big Data Platform · born 1978
- Ms. Junling GuoDeputy GM, Director & Board Secretary · born 1973